Larimar Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2014 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Larimar Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2014 to Q2 2024.
  • Larimar Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 6, 2024 was 63.8M shares, a 47.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 63.8M +20.5M +47.4% Aug 6, 2024 10-Q 2024-08-08
Q1 2024 63.8M +20.5M +47.4% Mar 12, 2024 10-K 2024-03-14
Q3 2023 43.9M +637K +1.47% Nov 12, 2023 10-Q 2023-11-14
Q2 2023 43.3M +25.6M +144% Aug 7, 2023 10-Q 2023-08-10
Q1 2023 43.3M +25.6M +144% Mar 13, 2023 10-K 2023-03-14
Q3 2022 43.3M +25.6M +144% Nov 8, 2022 10-Q 2022-11-10
Q2 2022 17.7M 0 0% Aug 9, 2022 10-Q 2022-08-11
Q1 2022 17.7M +2.34M +15.2% Mar 23, 2022 10-K 2022-03-25
Q3 2021 17.7M +2.35M +15.3% Nov 10, 2021 10-Q 2021-11-12
Q2 2021 17.7M +2.35M +15.3% Aug 10, 2021 10-Q 2021-08-12
Q1 2021 15.4M -22.1M -59% Mar 2, 2021 10-K 2021-03-04
Q3 2020 15.4M -22M -58.9% Oct 31, 2020 10-Q 2020-11-12
Q2 2020 15.4M -22M -58.9% Jul 31, 2020 10-Q 2020-08-14
Q1 2020 37.5M +143K +0.38% Apr 30, 2020 10-Q 2020-05-07
Q3 2019 37.4M +503K +1.37% Oct 31, 2019 10-Q 2019-11-06
Q2 2019 37.4M +565K +1.53% Jul 31, 2019 10-Q 2019-08-08
Q1 2019 37.3M +9.76M +35.4% Apr 30, 2019 10-Q 2019-05-09
Q3 2018 36.9M +9.38M +34.1% Oct 31, 2018 10-Q 2018-11-09
Q2 2018 36.8M +9.32M +33.9% Jul 31, 2018 10-Q 2018-08-09
Q1 2018 27.6M +190K +0.7% Apr 30, 2018 10-Q 2018-05-10
Q3 2017 27.5M +157K +0.57% Oct 31, 2017 10-Q 2017-11-07
Q2 2017 27.5M +155K +0.57% Jul 31, 2017 10-Q 2017-08-09
Q1 2017 27.4M +104K +0.38% Apr 30, 2017 10-Q 2017-05-09
Q3 2016 27.3M +98K +0.36% Oct 31, 2016 10-Q 2016-11-09
Q2 2016 27.3M +206K +0.76% Jul 31, 2016 10-Q 2016-08-05
Q1 2016 27.3M +413K +1.54% Mar 7, 2016 10-K 2016-03-15
Q3 2015 27.2M +4.53M +19.9% Oct 30, 2015 10-Q 2015-11-13
Q2 2015 27.1M +4.42M +19.5% Jul 31, 2015 10-Q 2015-08-14
Q1 2015 26.9M Mar 17, 2015 10-K 2015-03-25
Q3 2014 22.7M Nov 11, 2014 10-Q 2014-11-13
Q2 2014 22.7M Aug 11, 2014 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.